Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
The Lancet. Infectious Diseases
|
September 17, 2016
Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research
Elizabeth J A Fitchett, Anna C Seale, Stefania Vergnano, et al.
The Journal of Infectious Diseases
|
September 3, 2014
Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study
Steve M Taylor, Christian M Parobek, Derrick K DeConti, et al.
Journal of Global Health
|
June 9, 2020
Impact of routine vaccination against <i>Haemophilus influenzae</i> type b in The Gambia: 20 years after its introduction
Syed Ma Zaman, Stephen Rc Howie, Magnus Ochoge, et al.
The Lancet. Infectious Diseases
|
November 3, 2022
Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study
Khalid B Beshir, Julian Muwanguzi, Johanna Nader, et al.
Plos Genetics
|
May 30, 2013
Imputation-based meta-analysis of severe malaria in three African populations
Gavin Band, Quang Si Le, Luke Jostins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 26, 2016
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants
Muhammed O Afolabi, Alfred B Tiono, Uche J Adetifa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 4, 2017
Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants
Carly M Bliss, Abdoulie Drammeh, Georgina Bowyer, et al.
Plos One
|
March 26, 2013
Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults
Caroline Ogwang, Muhammed Afolabi, Domtila Kimani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 14, 2012
Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial
Lorenz von Seidlein, Rasaq Olaosebikan, Ilse C E Hendriksen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 17, 2014
Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations
Domtila Kimani, Ya Jankey Jagne, Momodou Cox, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
The Lancet. Infectious Diseases
|
September 17, 2016
Strengthening the Reporting of Observational Studies in Epidemiology for Newborn Infection (STROBE-NI): an extension of the STROBE statement for neonatal infection research
Elizabeth J A Fitchett, Anna C Seale, Stefania Vergnano, et al.
The Journal of Infectious Diseases
|
September 3, 2014
Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study
Steve M Taylor, Christian M Parobek, Derrick K DeConti, et al.
Journal of Global Health
|
June 9, 2020
Impact of routine vaccination against <i>Haemophilus influenzae</i> type b in The Gambia: 20 years after its introduction
Syed Ma Zaman, Stephen Rc Howie, Magnus Ochoge, et al.
The Lancet. Infectious Diseases
|
November 3, 2022
Prevalence of Plasmodium falciparum haplotypes associated with resistance to sulfadoxine-pyrimethamine and amodiaquine before and after upscaling of seasonal malaria chemoprevention in seven African countries: a genomic surveillance study
Khalid B Beshir, Julian Muwanguzi, Johanna Nader, et al.
Plos Genetics
|
May 30, 2013
Imputation-based meta-analysis of severe malaria in three African populations
Gavin Band, Quang Si Le, Luke Jostins, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
April 26, 2016
Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants
Muhammed O Afolabi, Alfred B Tiono, Uche J Adetifa, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
February 4, 2017
Viral Vector Malaria Vaccines Induce High-Level T Cell and Antibody Responses in West African Children and Infants
Carly M Bliss, Abdoulie Drammeh, Georgina Bowyer, et al.
Plos One
|
March 26, 2013
Safety and immunogenicity of heterologous prime-boost immunisation with Plasmodium falciparum malaria candidate vaccines, ChAd63 ME-TRAP and MVA ME-TRAP, in healthy Gambian and Kenyan adults
Caroline Ogwang, Muhammed Afolabi, Domtila Kimani, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 14, 2012
Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial
Lorenz von Seidlein, Rasaq Olaosebikan, Ilse C E Hendriksen, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
June 17, 2014
Translating the immunogenicity of prime-boost immunization with ChAd63 and MVA ME-TRAP from malaria naive to malaria-endemic populations
Domtila Kimani, Ya Jankey Jagne, Momodou Cox, et al.
Page
of 7